Conference call
Today at 2.00 p.m. (CET), ALK-Abelló holds a conference call for analysts and investors at which President and CEO Jens Bager and Executive Vice President R&D, Dr. Henrik Jacobi will review the announcement issued on Friday, November 16, 2007 regarding results from the American Phase III study with the company’s grass tablet. The review will be followed by a Q&A session.
All participants must call in on tel +45 7026 5040 before 1.55 p.m. (CET). The conference call will subsequently be available for replay on our website www.alk-abello.com.
Further inquiries may also be directed to Investor Relations at Schering-Plough, Robyn Brown on tel +1 908 298 7417.